GALWAY, IRELAND--February 5, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.K. pharmaceutical company AstraZeneca is planning to invest $500 million over five years in its French research and manufacturing operations. Within this article: Details investment plans for France over five years, financial performance, sale of drug lines
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
